HopeStage
Back to all studies
CompletedNCT00113594

Olanzapine safety and how the body processes it in adolescents

About this title

Olanzapine Treated Adolescents With Schizophrenia or Bipolar I Disorder

Read the official source — NCT00113594
Medication studyAges 13–17United States + RussiaBipolarity
The study in practice

Understand this study

Who was this study for?

Listed age limits: 13 years to 17 years.

Listed locations
Cerritos and 16 more locationsSee all locations and recruitment
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateJune 2005
Recruitment status
Completed
Enrollment listed in the registry
100
Sponsor
Eli Lilly and Company
Sponsor type
Other organization
Study type
Drug
Intervention type
Drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
United States, Russia
Age range
From 13 Years to 17 Years
Official registry ID
NCT00113594
Official title
Show the full official title

Population Pharmacokinetic Study in Adolescent Patients With Schizophrenia or Bipolar I Disorder Treated With Olanzapine

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Cerritos, United States · National City, United States · Poway, United States

15 more locations
  • Fort Lauderdale, United States
  • Eagle, United States
  • Lake Charles, United States
  • Glen Burnie, United States
  • Albuquerque, United States
  • New York, United States
  • Olean, United States
  • Cincinnati, United States
  • Houston, United States
  • Portsmouth, United States
  • Kirkland, United States
  • West Allis, United States
  • San Juan, Puerto Rico
  • Moscow, Russia
  • Russia

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Eli Lilly and Company.

Did this study involve medication?

Yes. The study involved medication, including Olanzapine.

Who was this study for?

Listed age limits: 13 years to 17 years.

Want to explore more studies?

Explore studies